ACM Research Inc

Market Summary

USD16.00-0.12

Delayed

-0.74%

ACMR Alerts

4 major insider sales recently.
Big jump in Revenue (Y/Y)

ACMR Stock Price

View Fullscreen

ACMR RSI Chart

ACMR Alerts

4 major insider sales recently.
Big jump in Revenue (Y/Y)

ACMR Valuation

Market Cap

958.4M

Price/Earnings (Trailing)

13.41

Price/Sales (Trailing)

1.93

EV/EBITDA

6.73

Price/Free Cashflow

-5.88

ACMR Price/Sales (Trailing)

ACMR Profitability

Operating Margin

50.60%

EBT Margin

20.49%

Return on Equity

8.14%

Return on Assets

5.07%

Free Cashflow Yield

-17.01%

ACMR Fundamentals

ACMR Revenue

Revenue (TTM)

495.9M

Revenue Y/Y

26.07%

Revenue Q/Q

16.59%

ACMR Earnings

Earnings (TTM)

71.5M

Earnings Y/Y

22.26%

Earnings Q/Q

-4.27%

Price Action

Last 7 days

-5.1%

Last 30 days

-9.5%

Last 90 days

-14.6%

Trailing 12 Months

77.8%

How does ACMR drawdown profile look like?

ACMR Financial Health

Current Ratio

2.32

ACMR Investor Care

Shares Dilution (1Y)

1.22%

Diluted EPS (TTM)

1.1

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	420.9M	461.1M	495.9M	0
2022	258.2M	308.7M	375.4M	388.8M
2021	176.0M	190.8M	210.2M	259.8M
2020	111.4M	121.4M	135.7M	156.6M
2019	85.4M	93.5M	103.8M	107.5M
2018	40.6M	52.7M	71.0M	74.6M
2017	29.7M	31.9M	34.2M	36.5M
2016	0	0	0	27.4M

Get all data in R, Python etc through our Historical Stock Data APIs

Latest Insider Trading transactions for ACMR

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Nov 29, 2023	wang david h	sold	-1,452,660	17.1353	-84,776	see remarks
Nov 29, 2023	dun haiping	sold	-327,474	17.25	-18,984	-
Nov 22, 2023	dun haiping	sold	-264,900	17.66	-15,000	-
Nov 22, 2023	wang david h	sold	-1,590,750	17.675	-90,000	see remarks
Nov 20, 2023	liu tracy	sold	-268,650	17.91	-15,000	-
Nov 20, 2023	liu tracy	acquired	110,400	7.36	15,000	-
Nov 14, 2023	wang david h	sold (taxes)	-90,009	17.23	-5,224	see remarks
Nov 14, 2023	wang david h	acquired	90,000	0.5	180,000	see remarks
Nov 14, 2023	dun haiping	acquired	17,500	0.5	35,000	-
Nov 14, 2023	dun haiping	sold (taxes)	-17,505	17.23	-1,016	-

Which funds bought or sold ACMR recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Dec 06, 2023	CITIGROUP INC	reduced	-0.73	8,702,100	31,966,600	0.02%
Nov 24, 2023	DEUTSCHE BANK AG\	added	14.3	164,478	446,810	-%
Nov 22, 2023	Graham Capital Management, L.P.	sold off	-100	-544,428	-	-%
Nov 21, 2023	Walleye Trading LLC	reduced	-37.11	-53,836	362,082	-%
Nov 21, 2023	Walleye Capital LLC	sold off	-100	-302,802	-	-%
Nov 16, 2023	McIlrath & Eck, LLC	added	72.46	2,504	4,309	-%
Nov 15, 2023	GSA CAPITAL PARTNERS LLP	reduced	-43.11	-270,000	999,000	0.09%
Nov 15, 2023	Penserra Capital Management LLC	new	-	3,254,000	3,254,000	0.07%
Nov 15, 2023	MORGAN STANLEY	added	160	7,736,930	10,701,600	-%
Nov 15, 2023	MANUFACTURERS LIFE INSURANCE COMPANY, THE	reduced	-1.56	91,848	345,208	-%

Latest Funds Activity

Are funds buying ACMR calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own ACMR

No. of Funds

Schedule 13G FIlings of ACM Research Inc

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Jul 18, 2023	shanghai science & technology venture capital (group) co., ltd.	6.3%	3,438,510	SC 13D/A
Jul 18, 2023	shanghai science & technology venture capital (group) co., ltd.	6.3%	3,438,510	SC 13G/A
Jun 13, 2023	shanghai science & technology venture capital (group) co., ltd.	6.3%	3,438,510	SC 13D
Jun 13, 2023	shanghai science & technology venture capital (group) co., ltd.	6.3%	3,438,510	SC 13G
Feb 14, 2023	yiheng capital management, l.p.	9.69%	5,266,800	SC 13G/A
Feb 13, 2023	blackrock inc.	5.9%	3,221,430	SC 13G
Feb 09, 2023	vanguard group inc	5.33%	2,899,420	SC 13G
Feb 09, 2023	morgan stanley	0.7%	390,606	SC 13G/A
Feb 08, 2023	morgan stanley	5.1%	2,773,504	SC 13G/A
Feb 14, 2022	yiheng capital management, l.p.	8.20%	1,415,100	SC 13G

Recent SEC filings of ACM Research Inc

View All Filings

Date Filed	Form Type	Document
Dec 08, 2023	8-K	Current Report
Dec 01, 2023	4	Insider Trading
Dec 01, 2023	4	Insider Trading
Nov 29, 2023	144	Notice of Insider Sale Intent
Nov 29, 2023	144	Notice of Insider Sale Intent
Nov 27, 2023	4	Insider Trading
Nov 27, 2023	4	Insider Trading
Nov 22, 2023	144	Notice of Insider Sale Intent
Nov 22, 2023	144	Notice of Insider Sale Intent
Nov 22, 2023	4	Insider Trading

Peers (Alternatives to ACM Research Inc)

View All Peers In Detail

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
NVDA	1.2T	44.9B	2.01%	176.71%	62.2	26.18	57.07%	217.10%
AMD	208.2B	22.1B	13.51%	82.97%	1.0K	9.42	-3.14%	-90.85%
INTC	180.0B	52.9B	12.61%	51.97%	-109.5	3.41	-23.98%	-112.36%
AMAT	123.8B	26.5B	2.42%	36.33%	19.21	4.66	5.50%	-3.05%
ADI	91.7B	12.3B	9.45%	9.48%	27.68	7.46	2.43%	20.59%
MID-CAP
AMKR	7.1B	6.7B	23.06%	6.76%	17.39	1.06	-3.65%	-50.30%
CRUS	4.3B	1.8B	9.02%	1.07%	30.6	2.45	-10.70%	-59.88%
ACLS	4.0B	1.1B	-5.85%	49.75%	17.32	3.7	26.38%	43.48%
DIOD	3.3B	1.8B	7.92%	-18.08%	11.26	1.8	-7.52%	-3.55%
AMBA	2.3B	290.7M	16.64%	-27.14%	-23.52	7.93	-17.79%	-146.17%
SMALL-CAP
ACMR	958.4M	495.9M	-9.50%	77.78%	13.41	1.93	32.10%	66.11%
AEHR	744.7M	74.9M	9.06%	1.17%	39.95	9.94	34.12%	99.53%
AOSL	630.4M	663.5M	7.12%	-29.81%	-79.92	0.95	-16.96%	-101.73%
ATOM	181.5M	-	33.84%	-2.49%	-9.32	576.4	-4.50%	-12.39%
ASYS	92.2M	117.9M	-5.48%	-25.65%	25.5	0.78	19.93%	-73.89%

ACM Research Inc News

Latest updates

Knox Daily • 04 Dec 2023 • 01:44 pm • 6 days ago

The Attractiveness of Investing In ACM Research Inc (ACMR) is ...

Simply Wall St • 27 Nov 2023 • 08:00 am • 13 days ago

ACM Research, Inc.'s (NASDAQ:ACMR) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Yahoo Finance • 22 Nov 2023 • 08:00 am • 18 days ago

Implied Volatility Surging for ACM Research (ACMR) Stock Options

Yahoo Finance • 22 Nov 2023 • 08:00 am • 18 days ago

Insider Sell Alert: Director Tracy Liu Sells 15,000 Shares of ACM ...

GuruFocus.com • 21 Nov 2023 • 08:00 am • 19 days ago

ACM Research (ACMR): A Smart Investment or a Value Trap? An In ...

Yahoo Finance • 16 Nov 2023 • 08:00 am • 24 days ago

12 Best-Performing Growth Stocks in 2023

Defense World • 12 Nov 2023 • 09:28 am • 28 days ago

ACM Research, Inc. (NASDAQ:ACMR) Shares Acquired by Allspring ...

GuruFocus.com • 09 Nov 2023 • 08:00 am • 31 days ago

ACM Research (ACMR): Uncovering the Significantly Undervalued ...

Yahoo Finance • 08 Nov 2023 • 08:00 am • 32 days ago

ACM Research, Inc. (NASDAQ:ACMR) Q3 2023 Earnings Call ...

Yahoo Finance • 30 Oct 2023 • 07:00 am • 41 days ago

ACM Research, Inc. (NASDAQ:ACMR) Stock's Been Sliding But ...

Benzinga • 27 Oct 2023 • 07:00 am • 44 days ago

Why Barnes Group Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Friday’s Mid-Day

GlobeNewswire • 19 Oct 2023 • 07:00 am • 52 days ago

ACM Research to Release Third Quarter 2023 Preliminary Revenue ...

Simply Wall St • 12 Oct 2023 • 07:00 am • 59 days ago

There's Been No Shortage Of Growth Recently For ACM Research's (NASDAQ:ACMR) Returns On Capital

Nasdaq • 02 Oct 2023 • 07:00 am • 2 months ago

Bull of the Day: ACM Research (ACMR)

The Motley Fool • 01 Oct 2023 • 07:00 am • 2 months ago

Wall Street Thinks This 1 Stock Could Be "the Next Nvidia" -- Is It a ...

Financials for ACM Research Inc

Income Statement (Last 12 Months)
(In Millions)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3
Revenue	16.6%	169	145	74.00	109	134	104	42.00	95.00	67.00	54.00	44.00	46.00	48.00	39.00	24.00	25.00	33.00	29.00	20.00	21.00	23.00
Cost Of Revenue	5.4%	80.00	76.00	34.00	55.00	68.00	60.00	23.00	50.00	37.00	32.00	26.00	26.00	27.00	20.00	14.00	12.00	17.00	16.00	12.00	11.00	13.00
Gross Profit	29.0%	89.00	69.00	40.00	54.00	66.00	44.00	20.00	45.00	30.00	22.00	18.00	20.00	20.00	19.00	10.00	12.00	16.00	13.00	9.00	10.00	10.00
Operating Expenses	44.8%	55.00	38.00	31.00	37.00	34.00	24.00	29.00	26.00	18.00	17.00	15.00	14.00	13.00	12.00	9.00	9.00	9.00	8.00	7.00	8.00	7.00
S&GA Expenses	46.9%	17.00	11.00	9.00	12.00	13.00	8.00	7.00	9.00	6.00	6.00	5.00	5.00	4.00	5.00	3.00	3.00	4.00	3.00	2.00	2.00	3.00
R&D Expenses	30.3%	26.00	20.00	14.00	18.00	16.00	11.00	17.00	13.00	8.00	8.00	6.00	6.00	4.00	5.00	4.00	3.00	3.00	3.00	3.00	4.00	2.00
EBITDA Margin	-11.1%	0.22*	0.25*	0.23*	0.19*	0.21*	0.16*	0.13*	0.18*	0.15*	0.15*	0.13*	0.14*	0.13*	0.15*	0.19*	0.19*	0.20*	0.17*	0.16*	0.12*	0.12*
Interest Expenses	-1.4%	1.00	1.00	1.00	1.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Income Taxes	-90.6%	1.00	8.00	3.00	3.00	10.00	8.00	-4.01	3.00	-0.27	0.00	-2.77	-2.80	-1.75	2.00	0.00	-1.18	-0.33	1.00	0.00	0.00	0.00
Earnings Before Taxes	-23.1%	32.00	41.00	12.00	17.00	38.00	24.00	-11.45	22.00	11.00	7.00	3.00	6.00	8.00	2.00	2.00	3.00	9.00	5.00	2.00	2.00	4.00
EBT Margin	-12.1%	0.20*	0.23*	0.22*	0.17*	0.19*	0.15*	0.11*	0.17*	0.13*	0.13*	0.11*	0.12*	0.12*	0.14*	0.17*	0.18*	0.18*	0.15*	0.14*	0.10*	0.12*
Net Income	-4.3%	26.00	27.00	7.00	12.00	21.00	12.00	-5.79	16.00	10.00	7.00	5.00	9.00	9.00	-0.08	2.00	4.00	9.00	4.00	2.00	2.00	4.00
Net Income Margin	-0.5%	0.14*	0.14*	0.12*	0.10*	0.11*	0.10*	0.10*	0.15*	0.15*	0.15*	0.13*	0.12*	0.10*	0.12*	0.17*	0.18*	0.17*	0.13*	0.13*	0.09*	0.11*
Free Cashflow	-9358.5%	-45.78	-0.48	-45.39	-71.34	-15.39	-35.65	-30.90	-40.36	-6.77	-11.39	9.00	-7.14	1.00	-15.89	4.00	14.00	-0.65	-1.63	-3.30	9.00	1.00

Balance Sheet
(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3
Assets	7.1%	1,410	1,317	1,313	1,236	1,148	1,072	1,087	1,052	470	419	372	341	297	257	217	218	180	120	111	103	89.00
Current Assets	11.9%	1,116	997	994	964	971	901	905	953	377	329	287	261	252	206	198	198	164	108	100	96.00	83.00
Cash Equivalents	-19.3%	208	257	260	248	336	324	380	563	65.00	70.00	79.00	72.00	92.00	86.00	52.00	118	47.00	28.00	27.00	27.00	18.00
Inventory	7.7%	507	471	473	393	328	288	272	218	177	137	103	89.00	64.00	50.00	45.00	45.00	44.00	45.00	42.00	39.00	30.00
Net PPE	20.0%	191	159	150	83.00	66.00	57.00	58.00	14.00	10.00	9.00	9.00	8.00	6.00	4.00	3.00	4.00	4.00	3.00	4.00	4.00	4.00
Liabilities	10.0%	532	484	480	423	374	284	279	241	227	189	157	133	106	106	59.00	60.00	62.00	61.00	56.00	51.00	40.00
Current Liabilities	5.6%	482	456	450	396	346	253	244	206	195	162	128	103	96.00	97.00	51.00	54.00	56.00	53.00	49.00	46.00	35.00
Short Term Borrowings	-37.2%	34.00	54.00	57.00	56.00	51.00	5.00	10.00	10.00	15.00	22.00	23.00	26.00	28.00	26.00	4.00	14.00	16.00	15.00	13.00	9.00	10.00
LT Debt, Current	107.4%	7.00	3.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	-	-	-	-	-	-	-	-	-
LT Debt, Non Current	150.0%	40.00	16.00	18.00	19.00	19.00	21.00	22.00	23.00	23.00	19.00	17.00	18.00	-	-	-	-	-	-	-	-	-
Shareholder's Equity	26.9%	878	692	692	675	643	787	809	812	243	230	215	208	191	151	99.00	97.00	91.00	60.00	56.00	52.00	49.00
Retained Earnings	22.5%	152	124	101	94.00	91.00	70.00	66.00	64.00	56.00	46.00	40.00	34.00	26.00	17.00	17.00	16.00	12.00	3.00	-1.53	-3.39	-5.67
Additional Paid-In Capital	1.2%	620	613	606	604	601	599	597	595	111	109	105	102	100	76.00	84.00	83.00	83.00	58.00	57.00	57.00	56.00
Shares Outstanding	-100.0%	-	60.00	60.00	-	59.00	59.00	59.00	-	58.00	57.00	56.00	-	55.00	54.00	54.00	-	51.00	48.00	48.00	-	48.00
Minority Interest	5.4%	149	141	141	137	131	132	134	135	69.00	69.00	67.00	67.00	64.00	61.00	-	-	-	-	-	-	-

Cashflow (Last 12 Months)
(In Thousands)

Cashflow (Quarterly)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3
Cashflow From Operations	-385.8%	-17,877,000	6,254,000	-30,494,000	1,336,000	-2,233,000	-33,568,000	-27,729,000	-36,271,000	-4,063,000	-10,501,000	10,742,000	-5,511,000	2,615,000	-14,480,000	3,829,000	14,155,000	-145,000	-1,425,000	-3,182,000	9,642,000	1,385,000
Share Based Compensation	424.6%	10,581,000	2,017,000	2,068,000	2,494,000	1,893,000	1,969,000	1,374,000	1,294,000	1,278,000	1,335,000	1,210,000	1,305,000	2,779,000	855,000	689,000	653,000	1,557,000	618,000	744,000	592,000	411,000
Cashflow From Investing	-1860.7%	-48,782,000	-2,488,000	49,129,000	-108,890,000	-6,541,000	6,120,000	-156,359,000	-5,803,000	-2,693,000	-1,206,000	-1,578,000	-35,297,000	-3,501,000	-31,034,000	-118,000	-237,000	-4,789,000	-389,000	-116,000	-123,000	-909,000
Cashflow From Financing	-26.1%	3,599,000	4,869,000	-1,455,000	9,435,000	41,407,000	-4,999,000	28,000	539,071,000	-976,000	2,051,000	-1,380,000	18,276,000	3,261,000	20,856,000	-9,559,000	28,270,000	53,326,000	2,588,000	3,261,000	-491,000	418,000
Buy Backs	-	-	-	-	-	-	-	-	-	-	-	-	-	-	9,715,000	-	2,042,000	2,827,000	-	-	-	-

ACMR Income Statement

2023-09-30

Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
Revenue (note 3)	$ 168,569	$ 133,709	$ 387,402	$ 280,290
Cost of revenue (note 16)	80,055	67,742	190,263	150,480
Gross profit	88,514	65,967	197,139	129,810
Operating expenses:
Sales and marketing	16,803	13,133	37,579	27,494
Research and development	26,151	15,678	60,244	44,391
General and administrative	12,387	5,520	26,851	15,560
Total operating expenses	55,341	34,331	124,674	87,445
Income from operations	33,173	31,636	72,465	42,365
Interest income	2,152	2,016	6,283	5,965
Interest expense	(640)	(419)	(1,984)	(986)
Realized gain from sale of short-term investments	656	1,136	8,569	1,136
Unrealized loss on short-term investments	(1,319)	(5,281)	(4,428)	(9,562)
Other income (expense), net	(2,150)	7,207	156	9,949
Income (loss) from equity method investments	(160)	1,251	3,728	1,652
Income before income taxes	31,712	37,546	84,789	50,519
Income tax expense (note 19)	(718)	(10,470)	(11,235)	(14,138)
Net income	30,994	27,076	73,554	36,381
Less: Net income attributable to non-controlling interests	5,315	6,072	13,905	8,927
Net income attributable to ACM Research, Inc.	25,679	21,004	59,649	27,454
Net income available to common stockholders, diluted	25,218	20,683	58,311	26,989
Comprehensive income (loss):
Net income	30,994	27,076	73,554	36,381
Foreign currency translation adjustment, net of tax	4,015	(42,416)	(21,831)	(80,334)
Comprehensive income (loss)	35,009	(15,340)	51,723	(43,953)
Less: Comprehensive income (loss) attributable to non-controlling interests	7,768	(1,057)	11,882	(4,378)
Comprehensive income (loss) attributable to ACM Research, Inc.	$ 27,241	$ (14,283)	$ 39,841	$ (39,575)
Net income attributable to ACM Research, Inc. per share of common stock (note 2):
Basic (in dollars per share)	$ 0.43	$ 0.35	$ 0.99	$ 0.46
Diluted (in dollars per share)	$ 0.39	$ 0.32	$ 0.90	$ 0.41
Weighted average shares of common stock outstanding used in computing per share amounts (note 2):
Basic (in shares)	60,219,218	59,360,790	59,953,144	59,123,895
Diluted (in shares)	65,450,941	65,612,665	64,834,051	65,629,273

ACMR Balance Sheet

2023-09-30

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents (note 2)	$ 207,101	$ 247,951
Restricted cash	560	500
Short-term time deposits (note 2)	75,651	70,492
Short-term investments (note 15)	21,844	20,209
Accounts receivable, net (note 4)	248,477	182,936
Inventories, net (note 5)	507,431	393,172
Prepaid expenses	17,540	15,607
Total current assets	1,115,894	963,806
Property, plant and equipment, net (note 6)	190,882	82,875
Land use right, net (note 7)	8,299	8,692
Operating lease right-of-use assets, net (note 11)	7,184	2,489
Intangible assets, net	2,163	1,255
Long-term time deposits (note 2)	43,183	101,956
Deferred tax assets (note 19)	16,486	6,703
Long-term investments (note 14)	22,306	17,459
Other long-term assets (note 8)	3,851	50,265
Total assets	1,410,248	1,235,500
Current liabilities:
Other payables and accrued expenses (note 10)	80,400	52,201
Advances from customers	191,393	153,773
Current portion of operating lease liabilities (note 11)	2,876	1,382
Deferred revenue	4,747	4,174
Short-term borrowings (note 9)	33,911	56,004
Current portion of long-term borrowings (note 12)	6,717	2,322
Income taxes payable (note 19)	11,061	3,469
FIN-48 payable (note 19)	6,487	6,686
Total current liabilities	481,951	396,214
Long-term borrowings (note 12)	39,753	18,687
Long-term operating lease liabilities (note 11)	4,308	1,107
Other long-term liabilities (note 13)	6,106	7,321
Total liabilities	532,118	423,329
Commitments and contingencies (note 20)
Equity:
Additional paid-in capital	620,210	604,089
Retained earnings	152,306	94,426
Statutory surplus reserve (note 22)	16,881	16,881
Accumulated other comprehensive loss	(60,354)	(40,546)
Total ACM Research, Inc. stockholders’ equity	729,050	674,856
Non-controlling interests	149,080	137,315
Total equity	878,130	812,171
Total liabilities and equity	1,410,248	1,235,500
Related Party
Current assets:
Other receivables	1,164	3,322
Current liabilities:
Accounts payable	7,684	14,468
Nonrelated Party
Current assets:
Other receivables	36,126	29,617
Current liabilities:
Accounts payable	136,675	101,735
Class A Common Stock
Equity:
Common stock	6	5
Class B Common Stock
Equity:
Common stock	$ 1	$ 1

About ACM Research Inc

ACM Research, Inc., together with its subsidiaries, develops, manufactures, and sells single-wafer wet cleaning equipment for enhancing the manufacturing process and yield for integrated chips worldwide. It offers space alternated phase shift technology for flat and patterned wafer surfaces, which employs alternating phases of megasonic waves to deliver megasonic energy in a uniform manner on a microscopic level; timely energized bubble oscillation technology for patterned wafer surfaces at advanced process nodes, which provides cleaning for 2D and 3D patterned wafers; Tahoe technology for delivering cleaning performance using less sulfuric acid and hydrogen peroxide; and electro-chemical plating technology for advanced metal plating. The company markets and sells its products under the Ultra C brand name through direct sales force and third-party representatives. ACM Research, Inc. was incorporated in 1998 and is headquartered in Fremont, California.

CEO	Dr. Hui Wang Ph.D.
WEBSITE	www.acmrcsh.com
EMPLOYEES	1209

ACM Research Inc Frequently Asked Questions

What is the ticker symbol for ACM Research Inc? What does ACMR stand for in stocks?

ACMR is the stock ticker symbol of ACM Research Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of ACM Research Inc (ACMR)?

As of Fri Dec 08 2023, market cap of ACM Research Inc is 958.37 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ACMR stock?

You can check ACMR's fair value in chart. The fair value of ACM Research Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of ACM Research Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for ACMR so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is ACM Research Inc a good stock to buy?

The fair value guage provides a quick view whether ACMR is over valued or under valued. Whether ACM Research Inc is cheap or expensive depends on the assumptions which impact ACM Research Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ACMR.

What is ACM Research Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Dec 08 2023, ACMR's PE ratio (Price to Earnings) is 13.41 and Price to Sales (PS) ratio is 1.93. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ACMR PE ratio will change depending on the future growth rate expectations of investors.

Market Summary

ACMR Alerts

ACMR Stock Price

ACMR RSI Chart

ACMR Alerts

ACMR Valuation

ACMR Price/Sales (Trailing)

ACMR Profitability

ACMR Fundamentals

ACMR Revenue

ACMR Earnings

Price Action

How does ACMR drawdown profile look like?

ACMR Financial Health

ACMR Investor Care

Historical Charts for Stock Metrics

Latest Insider Trading transactions for ACMR

Which funds bought or sold ACMR recently?

Latest Funds Activity

Schedule 13G FIlings of ACM Research Inc

Recent SEC filings of ACM Research Inc

Peers (Alternatives to ACM Research Inc)

ACM Research Inc News

Financials for ACM Research Inc

Income Statement (Last 12 Months).css-zgnqz2{margin:0;font-family:"Roboto","Helvetica","Arial",sans-serif;font-weight:400;font-size:0.75rem;line-height:1.66;letter-spacing:0.03333em;color:#595959;}(In Millions)

Balance Sheet(In Millions)

Cashflow (Last 12 Months)(In Thousands)

ACMR Income Statement

ACMR Balance Sheet

About ACM Research Inc

ACM Research Inc Frequently Asked Questions

What is the ticker symbol for ACM Research Inc? What does ACMR stand for in stocks?

What is the market capital of ACM Research Inc (ACMR)?

What is the fair value of ACMR stock?

Is ACM Research Inc a good stock to buy?

What is ACM Research Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

Income Statement (Last 12 Months)
(In Millions)

Balance Sheet
(In Millions)

Cashflow (Last 12 Months)
(In Thousands)